Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil

Acta Virologica

Volumn 40, Issue 1, 1996, Pages 27-33

  Friedrich, F ^a   Da Silva, E E ^a   Schatzmayr, H G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

mutation, neurovirulence; poliovirus; recombination; vaccine associated poliomyelitis

Indexed keywords

RNA POLYMERASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; POLIOMYELITIS; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 2; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BRAZIL; CAPSID; CAPSID PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RECOMBINATION, GENETIC; RNA, VIRAL;

EID: 20644433095     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Almond JW (1987): The attenuation of poliovirus neurovirulence. Ann. Rev. Microbiol. 41, 153-180.
2. Baker S, Richards OC, Ehrenfeld E (1995): Elongation activity of poliovirus RNA polymerase derived from Sabin type 1 sequence is not temperature sensitive. J. Gen. Virol. 76, 2081-2084.
3. Christodoulou C, Colbere-Garapin F, Macadam A, Taffs LF, Marsden S, Minor P, Horaud F (1990): Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J. Virol. 64, 4922-4929.
4. Zimmern D, Kaesberg P (1978): 3′-Terminal nucleotide sequence of encephalomyocarditis virus RNA determined by reverse transcriptase and chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 75, 4257-4261.